A new multicenter study, conducted in collaboration with the Jaeb Center for Health Research, found that the investigational SteadiSet™ insulin infusion set achieved a 95% 7-day survival rate in adults with Type 1 diabetes-surpassing the prespecified performance goal. The findings suggest a promising extended-wear option that could reduce set changes and improve patient convenience.
Full study: lnkd.in/gwxkyTSj DiabetesResearch DiabetesTechnology Type1Diabetes MedicalDevices ClinicalResearch
Congratulations to Dr. Jacob Kariuki (Kigo Kariuki), Associate Professor at Nell Hodgson Woodruff School of Nursing at Emory University on receiving an NIH R01 award to advance his research on Physical Activity for The Heart (PATH)!
Congratulations to GCDTR, Director and Emory Global Diabetes Research Center, Director of Data Analytics & Reporting, Dr. Jeff Mills, Ed.D, MBA on receiving an National Science Foundation (NSF)-supported ACCESS Discovery Project! ACCESS is a National Science Foundation-supported program that connects…
What factors influence corneal graft health after Descemet membrane endothelial keratoplasty (DMEK)?
